Details for: OGFR AS1

Gene ID: 101409261

Gene Type:  ncRNA (Non-coding RNA)  - A functional RNA molecule that is transcribed from DNA but not translated into a protein. Includes classes like miRNA and lncRNA.

Symbol: OGFR AS1

Ensembl ID: ENSG00000229873

Description: OGFR antisense RNA 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • neural progenitor cell CL0011020
    CSI 20.1
    rCSI 88.43%
    PRS 98.29
  • basal cell of epidermis CL0002187
    CSI 6.14
    rCSI 10.88%
    PRS 96.96
  • melanocyte of skin CL1000458
    CSI 4.54
    rCSI 6.18%
    PRS 97.94
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 2.3
    rCSI 2.79%
    PRS 97.81

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [OGFR AS1](/details-gene/101409261) is a long non-coding RNA (lncRNA) located on chromosome 20q13.33. As an antisense transcript to the Opioid Growth Factor Receptor (*OGFR*) gene, its primary function is likely the regulation of this key growth-inhibitory pathway. Expression data indicates that **Overall**, [OGFR AS1](/details-gene/101409261) is a highly significant and specific marker for [neural progenitor cell](/details-cell/CL0011020), with additional prominent roles in progenitor and specialized cells of the skin, including [basal cell of epidermis](/details-cell/CL0002187) and [melanocyte of skin](/details-cell/CL1000458). This expression pattern suggests a critical role in developmental processes, tissue homeostasis, and the control of cell proliferation. ## Cellular Roles and Expression Landscape **Overall**, the expression profile of [OGFR AS1](/details-gene/101409261) points to a specialized function in progenitor populations and terminally differentiated cells requiring tight proliferative control. The most striking feature of its expression is the exceptionally high significance in [neural progenitor cell](/details-cell/CL0011020) (CSI: 20.10), suggesting it is a key regulatory molecule in neurogenesis. Its presence in these cells is consistent with a role in modulating the balance between self-renewal and differentiation in the developing central nervous system. A second major functional context is the skin. [OGFR AS1](/details-gene/101409261) is significantly expressed in [basal cell of epidermis](/details-cell/CL0002187) (CSI: 6.14), the stem cell population responsible for epidermal regeneration, and in [melanocyte of skin](/details-cell/CL1000458) (CSI: 4.54). This co-expression in distinct skin cell lineages implies a role in maintaining skin homeostasis and potentially in the pathology of skin disorders. Finally, a more moderate but distinct signal is observed in [CD8-positive, alpha-beta memory T cell, CD45RO-positive](/details-cell/CL0001203) (CSI: 2.30). This may indicate a secondary function related to the long-term maintenance or proliferation of memory immune cells. The highly restricted expression pattern across these specific cell types suggests that [OGFR AS1](/details-gene/101409261) is likely not broadly expressed in many other differentiated tissues. ## Pathways and Molecular Function As a non-coding antisense RNA, [OGFR AS1](/details-gene/101409261) is presumed to exert its function primarily through the regulation of its sense-strand counterpart, the Opioid Growth Factor Receptor (*OGFR*). The *OGFR* pathway is a well-established endogenous system that tonically inhibits cell proliferation in a receptor-mediated and reversible manner. It is fundamental to processes such as development, cancer, and wound healing. The molecular function of [OGFR AS1](/details-gene/101409261) may involve several mechanisms, including transcriptional interference, modulation of mRNA stability, or alteration of the translational efficiency of *OGFR*. By forming an RNA-RNA duplex with the *OGFR* transcript, it could either promote its degradation or inhibit its translation, thereby relieving the growth-inhibitory brake and allowing for cell proliferation. Conversely, it could potentially stabilize the transcript or recruit activating factors. Its high expression in progenitor cells, which require precise control over proliferation, is strongly consistent with a functional role within this critical growth-regulatory axis. ## Research Directions The specific expression pattern of [OGFR AS1](/details-gene/101409261) in progenitor cells and its inferred function as a regulator of the growth-suppressive *OGFR* pathway make it a compelling subject for further investigation, particularly in the contexts of development and cancer. ### Testable Hypotheses 1. In neurogenesis, [OGFR AS1](/details-gene/101409261) functions as an antagonist of *OGFR* expression, thereby maintaining the proliferative capacity of [neural progenitor cell](/details-cell/CL0011020). Its subsequent downregulation is a prerequisite for terminal differentiation into neurons and glia. 2. Aberrant overexpression of [OGFR AS1](/details-gene/101409261) in [melanocyte of skin](/details-cell/CL1000458) contributes to melanoma development by suppressing the tumor-suppressive activity of the *OGFR* pathway, leading to uncontrolled cell division. ### Key Experiments To test the hypothesis that [OGFR AS1](/details-gene/101409261) controls the fate of [neural progenitor cell](/details-cell/CL0011020), a targeted knockdown of [OGFR AS1](/details-gene/101409261) could be performed in cultured human neural progenitor cells using antisense oligonucleotides (ASOs) or a CRISPRi system. The direct effect on *OGFR* mRNA and protein levels would be measured via RT-qPCR and Western blot. Functional consequences would be assessed by measuring changes in proliferation rates (e.g., EdU incorporation assay) and by analyzing markers of differentiation (e.g., Tuj1 for neurons, GFAP for astrocytes) via immunofluorescence after inducing differentiation. An increase in *OGFR* levels accompanied by reduced proliferation and premature differentiation would support the hypothesis. ### Therapeutic Potential Given its nature as a long non-coding RNA with a highly restricted expression profile, [OGFR AS1](/details-gene/101409261) could represent a novel therapeutic target. Its potential role in promoting proliferation by inhibiting the growth-suppressive *OGFR* pathway makes it particularly relevant for cancers arising from its cell types of origin, such as neuroblastoma or melanoma. The therapeutic strategy would likely involve **inhibition** of [OGFR AS1](/details-gene/101409261) function using sequence-specific molecules like ASOs. Such an approach could reactivate the endogenous *OGFR* braking mechanism to slow tumor growth, and the specificity of the lncRNA target may offer a favorable therapeutic window with limited off-target effects.